Envista Holdings Corporation delivered a strong performance in Q4 2025, with core sales growth of 10.8% and adjusted EBITDA growth of 22% year-on-year. The company also reported positive growth across all major businesses and geographies, improved employee engagement, and returned $166 million to shareholders through share repurchases for the full year.

Envista Holdings Corporation delivered first-quarter 2025 results in line with expectations, building on momentum from the second half of 2024. The company reported sales of $617 million, a net income of $18 million, and maintained its 2025 guidance.

Envista Holdings Corporation reported Q4 2024 sales of $653 million, a 2.0% increase in core sales over Q4 2023. The company achieved an adjusted EBITDA margin of 13.9% and generated $132 million in operating cash flow, an increase of 30% compared to the prior year.

Envista reported sales of $601.0 million. Net income was $8.2 million, or $0.05 per diluted share. Adjusted net income was $21.1 million, or $0.12 per diluted share. The company continues to expect a core sales growth of -1% to -4% for the full year 2024.

Envista reported Q2 2024 sales of $633.1 million with a net loss of $1,151.6 million, which included a $1,153.8 million non-cash charge. Core sales declined by 3.2%. The company is taking steps to improve future performance, including hiring a permanent CFO and Presidents for its two largest businesses, while making growth investments in its highest-margin businesses.

Envista Holdings Corporation reported first quarter 2024 sales of $623.6 million, with a net income of $23.6 million, or $0.14 per diluted share. Core sales increased by 0.4%. The company is focusing on improving Spark margins, accelerating the North American implant business, and optimizing the operating structure.

Envista reported Q4 2023 sales of $645.6 million, with a net loss of $217.4 million, including a $258.3 million non-cash charge. Adjusted net income was $49.7 million, and adjusted EBITDA was $100.5 million. The company's full-year results aligned with expectations, with the Orthodontic business outperforming, and Spark Aligner growing over 50%.

Envista reported Q3 2023 earnings with sales of $631.3 million and a core sales increase of 0.8%. Net income was $21.5 million, or $0.12 per diluted share, while adjusted net income was $75.5 million, or $0.43 per diluted share. The company is revising its full year guidance for 2023 due to macro uncertainty and investments in long-term growth.

Envista Holdings Corporation reported a 2.6% increase in sales to $662.4 million for Q2 2023. Core sales grew by 2.1%. Net income was $51.9 million, or $0.29 per diluted share, while adjusted net income was $76.2 million, or $0.43 per diluted share. The company reaffirmed its full-year guidance for 2023.

Envista reported a decrease in sales by 0.7% to $627.2 million, with core sales declining by 2.4%. Net income stood at $43.8 million, or $0.25 per diluted share, while adjusted net income was $67.8 million, or $0.38 per diluted share. The company is focused on long-term strategic priorities, expecting growth acceleration and margin expansion throughout 2023.

Envista Holdings Corporation reported a 1.4% increase in sales to $660.8 million for the fourth quarter of 2022, with core sales growth of 2.3%. Net income was $73.5 million, or $0.42 per diluted share, while adjusted net income was $91.9 million, or $0.52 per diluted share. Adjusted EBITDA for the quarter was $138.3 million.

Envista Holdings Corporation reported a 3.9% increase in sales to $631.1 million for the third quarter of 2022, with core sales growth of 4.9%. Net income was $49.6 million, or $0.28 per diluted share, while adjusted net income was $82.5 million, or $0.47 per diluted share. The company is reiterating its guidance for core growth and profitability for the full year 2022.

Envista Holdings Corporation announced Q2 2022 results with sales increasing 1.3% to $645.8 million and core sales growth of 4.0%. Net income was $44.5 million, or $0.25 per diluted share, while adjusted net income was $86.0 million, or $0.48 per diluted share. The company closed acquisitions of Carestream Dental’s Intraoral Scanner Business and Osteogenics' Regenerative Solutions business.

Envista reported a 3.1% increase in sales to $631.4 million, with a core sales growth of 5.4%. Net income was $70.4 million, or $0.39 per diluted share, while adjusted net income was $84.9 million, or $0.47 per diluted share. The company also completed the acquisition of Carestream Dental’s Intraoral Scanner (IOS) business.

Envista Holdings Corporation reported a 5.8% increase in sales to $651.8 million for the fourth quarter ended December 31, 2021, with core sales growth of 6.6%. Net income for the quarter was $42.5 million, or $0.24 per diluted share, while adjusted earnings per diluted share was $0.46. The company expects to deliver core growth of between 6-8% and deliver a full year adjusted EBITDA margin of >20% for 2022.

Envista Holdings Corporation reported an 11% increase in sales to $607.3 million and a core sales growth of 10.2% for the third quarter of 2021. Net income was $80.2 million, or $0.45 per diluted share, while adjusted earnings per diluted share was $0.45. The company raised its financial guidance for the year, projecting sales between $2.475 and $2.500 billion and adjusted EBITDA between $480 and $495 million.

Envista Holdings reported strong second-quarter results with sales of $740.1 million, a 104.4% increase year-over-year, and a core sales growth of 102.3%. Net income was $90.1 million, or $0.51 per diluted share, while adjusted net income reached $94.2 million, or $0.53 per diluted share. The adjusted EBITDA for the quarter was $140.4 million, reflecting a robust recovery and efficient operational performance.

Envista reported strong first-quarter results with sales of $709.2 million, a 29.6% increase year-over-year. Core sales grew by 29.7%. Net income was $71.7 million, or $0.41 per diluted share, while adjusted net income was $95.4 million, or $0.54 per diluted share.

Envista Holdings Corporation reported a net income of $108.4 million, or $0.64 per diluted share, for the fourth quarter of 2020. Sales for the quarter were $732.3 million, a 1.6% increase compared to the same period year-over-year. Core sales increased by 3.4%.

Envista Holdings Corporation reported Q3 2020 results with net income of $35.6 million, or $0.22 per share. Sales were $640.5 million, a 2.9% decrease year-over-year, but showed a 76.9% sequential improvement from Q2 2020. Free cash flow increased by 70.3% compared to the same period in 2019.

Envista Holdings Corporation reported a net loss of $93.5 million, or $0.59 per share, for Q2 2020. Adjusted net loss was $16.3 million, or $0.10 per diluted share. Sales for the quarter were $362.0 million, a 49.2% decrease compared to the same period year-over-year, with core sales declining 46.2%.

Envista reported a challenging first quarter in 2020, with a net loss of $17.2 million and a 17.1% decrease in sales compared to the previous year. The company's performance was significantly impacted by the COVID-19 pandemic, which led to a 14.6% decline in core sales. In response, Envista has taken immediate steps to ensure the safety of its employees, support its customers and partners, and preserve its financial strength. These actions include cost reduction measures and borrowing on its revolving credit facility.

Envista Holdings Corporation reported Q4 2019 results with net earnings of $56 million, or $0.35 per diluted share, and adjusted earnings of $85 million, or $0.52 per share. Sales for the quarter were $721 million, a 5.0% decrease year-over-year, with core sales declining 3.5%.